|
|
Volumn 1, Issue 1, 2005, Pages 19-28
|
|
In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIOXIDANT;
CD163 ANTIGEN;
CELL SURFACE RECEPTOR;
DIFFERENTIATION ANTIGEN;
HAPTOGLOBIN;
HAPTOGLOBIN HEMOGLOBIN COMPLEX;
HAPTOGLOBIN-HEMOGLOBIN COMPLEX;
HEMOGLOBIN;
HP PROTEIN, HUMAN;
LEUKOCYTE ANTIGEN;
LOW DENSITY LIPOPROTEIN;
OXIDIZED LOW DENSITY LIPOPROTEIN;
UNCLASSIFIED DRUG;
ANIMAL;
CARDIOVASCULAR DISEASE;
CHEMICAL STRUCTURE;
DIABETIC ANGIOPATHY;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
GENETIC POLYMORPHISM;
GENETIC PREDISPOSITION;
GENETIC SCREENING;
GENETICS;
GENOTYPE;
HUMAN;
METABOLISM;
OXIDATIVE STRESS;
PATIENT SELECTION;
PHENOTYPE;
PROTEIN QUATERNARY STRUCTURE;
RESTENOSIS;
REVIEW;
RISK;
RISK ASSESSMENT;
RISK FACTOR;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC;
ANTIOXIDANTS;
CARDIOVASCULAR DISEASES;
CORONARY RESTENOSIS;
DIABETIC ANGIOPATHIES;
DIABETIC NEPHROPATHIES;
DIABETIC RETINOPATHY;
GENETIC PREDISPOSITION TO DISEASE;
GENETIC SCREENING;
GENOTYPE;
HAPTOGLOBINS;
HEMOGLOBINS;
HUMANS;
LIPOPROTEINS, LDL;
MODELS, MOLECULAR;
ODDS RATIO;
OXIDATIVE STRESS;
PATIENT SELECTION;
PHENOTYPE;
POLYMORPHISM, GENETIC;
PROTEIN STRUCTURE, QUATERNARY;
RECEPTORS, CELL SURFACE;
RISK ASSESSMENT;
RISK FACTORS;
|
|
EID: 33947497535
PISSN: 11766344
EISSN: None
Source Type: Journal
DOI: 10.2147/vhrm.1.1.19.58930 Document Type: Review |
|
Times cited : (82)
|
|
References (74)
|
